Literature DB >> 32876702

Successful outcome of anaplastic multiple myeloma with lenalidomide, cyclophosphamide, and dexamethasone therapy.

Wenjiao Tang1, Yangfan Xu1, Bing Xiang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32876702     DOI： 10.1007/s00277-020-04244-7

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  7 in total

1.  Plasma cell myeloma with anaplastic transformation.

Authors:  Shenon Sethi; Ira Miller
Journal:  Blood       Date:  2016-10-20       Impact factor: 22.113

2.  Anaplastic plasmacytomas: relationships to normal memory B cells and plasma cell neoplasms of immunodeficient and autoimmune mice.

Authors:  Chen-Feng Qi; Dong-Mi Shin; Zhaoyang Li; Hongsheng Wang; Jianxum Feng; Janet W Hartley; Torgny N Fredrickson; Alexander L Kovalchuk; Herbert C Morse
Journal:  J Pathol       Date:  2010-05       Impact factor: 7.996

3.  Anaplastic multiple myeloma: possible limitations of conventional chemotherapy for long-term remission.

Authors:  Satoshi Ichikawa; Noriko Fukuhara; Shunsuke Hatta; Masahito Himuro; Kentaro Nasu; Koya Ono; Yoko Okitsu; Masahiro Kobayashi; Yasushi Onishi; Masaki Ri; Ryo Ichinohasama; Hideo Harigae
Journal:  J Clin Exp Hematop       Date:  2018

4.  Sustained remission and reversal of end-organ dysfunction in a patient with anaplastic myeloma.

Authors:  Mridul Agrawal; Jennifer Kanakry; Christina A Arnold; Daniel L Suzman; Luckson Mathieu; Yvette L Kasamon; Douglas E Gladstone; Richard F Ambinder; Nilanjan Ghosh
Journal:  Ann Hematol       Date:  2014-07       Impact factor: 3.673

5.  Anaplastic myeloma with massive extramedullary involvement. Report of two cases.

Authors:  K Foucar; M Raber; E Foucar; B Barlogie; C M Sandler; R Alexanian
Journal:  Cancer       Date:  1983-01-01       Impact factor: 6.860

6.  Genomic aberrations in anaplastic multiple myeloma: high frequency of 1q21(CKS1B) amplifications.

Authors:  Mohammad Bahmanyar; Xiaoying Qi; Hong Chang
Journal:  Leuk Res       Date:  2013-10-08       Impact factor: 3.156

7.  Poor response to daratumumab and carfilzomib in newly diagnosed anaplastic multiple myeloma.

Authors:  Masuho Saburi; Masao Ogata; Yasuhiro Soga; Yoshiyuki Kondo; Ryo Kurimoto; Kazuhito Itani; Kazuhiro Kohno; Hiroki Uchida; Toshiyuki Nakayama
Journal:  J Clin Exp Hematop       Date:  2020
  7 in total
  2 in total

1.  Anaplastic multiple myeloma with MYC rearrangement.

Authors:  Satoshi Ichikawa; Noriko Fukuhara; Ko Hashimoto; Fumiyoshi Fujishima; Ryo Ichinohasama; Hideo Harigae
Journal:  Leuk Res Rep       Date:  2021-12-27

2.  Anaplastic Multiple Myeloma: Case Series and Literature Review.

Authors:  Jian Wu; Emily Chu; Cristiana Costa Chase; Taewoong Choi; Cristina Gasparetto; Ken Young; Yubin Kang
Journal:  Asploro J Biomed Clin Case Rep       Date:  2022-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.